RxDoctor Payments Data

Lucian Warth, MD

Adult Reconstructive Orthopaedic Surgery · Carmel, INNPI 1548496003

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $211,635 of the $315,772 with a category attached, or 67.0%. 15 manufacturers reported payments, led by Encore Medical, LP at 49.3% of the total.

$315,772in general payments, 2019–2025

Across 433 payments — averaging $729.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Encore Medical, LP$156K
  • Medacta USA, Inc.$49K
  • Stryker$42K
  • Linkbio Corp$40K
  • Osteoremedies, LLC$25K
  • KCI USA, Inc.$3K
  • plus $1K from 9 others

What the payments were for

  • Royalty or licence$64,78421%
  • Consulting fees$211,63567%
  • Travel & lodging$25,5538%
  • Food & beverage$13,8004%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few adult reconstructive orthopaedic surgery providers in Indianato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$215,185
Medicare patients
491
Services billed
1,825

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib127$4,607
Amoxicillin49$48
Meloxicam17$45

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Carmel

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →